A. M. Vannucchi

Mutations and prognosis in primary myelofibrosis

A. M. Vannucchi, T L Lasho, Paola Guglielmelli et al. · Leukemia · 2013 · 739 citations

Hematological Malignancy, Hematology, Pathology +4

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Paola Guglielmelli, Terra L. Lasho, Giada Rotunno et al. · Leukemia · 2014 · 307 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Srđan Verstovšek, A. M. Vannucchi, Tamás Masszi et al. · Haematologica · 2016 · 156 citations · Full text

Hematological Malignancy, Polycythemia Vera, Urology +15

Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line

A. M. Vannucchi, A Grossi, Alberto Bosi et al. · Blood · 1993 · 25 citations · Full text

Internal Tandem Duplications of<i>Flt3</i>Gene (Flt3/ITD) Predicts a Poor Post-Remission Outcome in Adult Patients with Acute Non-Promyelocytic Leukemia

SE Ciolli, A. M. Vannucchi, Fabiana Leoni et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 23 citations